NASDAQ: TRAX
First Tracks Biotherapeutics Inc Stock Ownership - Who owns First Tracks Biotherapeutics?

Insider buying vs selling

Have First Tracks Biotherapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Ecor1 Capital LLC10% Owner2026-04-204,705,575$13.81
$65.00MSell

1 of 1

TRAX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TRAX insiders and whales buy or sell their stock.

TRAX Shareholders

What type of owners hold First Tracks Biotherapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ecor1 Capital LLC22.58%7,880,094$290.54MInsider
Daniel Faga1.42%496,684$18.31MInsider
Paul F. Lizzul0.12%42,669$1.57MInsider
John P. Schmid0.11%37,652$1.39MInsider
Rita Jain0.06%19,194$707.68kInsider
Benjamin Stone0.05%17,262$636.45kInsider
John A. Orwin0.05%16,695$615.54kInsider
Magda Marquet0.05%15,960$588.45kInsider
J. Anthony Ware0.04%15,660$577.38kInsider
Dennis M. Fenton0.03%10,995$405.39kInsider

1 of 2

TRAX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TRAX0.00%24.51%Net Selling
ABSI71.40%28.60%Net BuyingNet Selling
AKTS52.35%47.65%Net BuyingNet Buying
AVBP80.88%19.12%Net Selling
AVLN0.00%29.18%Net BuyingNet Buying

First Tracks Biotherapeutics Stock Ownership FAQ

Who owns First Tracks Biotherapeutics?

First Tracks Biotherapeutics (NASDAQ: TRAX) is owned by 0.00% institutional shareholders, 24.51% First Tracks Biotherapeutics insiders, and 75.49% retail investors. Ecor1 Capital LLC is the largest individual First Tracks Biotherapeutics shareholder, owning 7.88M shares representing 22.58% of the company. Ecor1 Capital LLC's First Tracks Biotherapeutics shares are currently valued at $294.48M.

If you're new to stock investing, here's how to buy First Tracks Biotherapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.